90TEN

90TEN is a global healthcare communications consultancy that specializes in medical communications, public relations, and patient advocacy. The company provides strategic consultancy services to pharmaceutical and life sciences organizations, focusing on behavioral science-led programs to improve health outcomes. In 2020, 90TEN was acquired by Envision Pharma Group, expanding its reach and capabilities within the global healthcare market. Their work often involves brand strategy, disease awareness campaigns, and stakeholder engagement. The agency is well-regarded for its 'FEEL-THINK-DO' methodology, which applies behavioral science to healthcare challenges. 90TEN has received numerous industry awards for its creative and impactful campaigns across various therapeutic areas.